Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP633841.RAPObBzUqI0R0L9irojKs8eFFZ17leYY9kCf1_zUzG-Zs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP633841.RAPObBzUqI0R0L9irojKs8eFFZ17leYY9kCf1_zUzG-Zs130_assertion type Assertion NP633841.RAPObBzUqI0R0L9irojKs8eFFZ17leYY9kCf1_zUzG-Zs130_head.
- NP633841.RAPObBzUqI0R0L9irojKs8eFFZ17leYY9kCf1_zUzG-Zs130_assertion description "[Increased soluble HLA-G (sHLA-G) levels have been reported in patients with melanoma, neuroblastoma, lymphoproliferative disorders, breast, ovarian and colorectal carcinoma when compared to healthy controls or subjects with benign neoplasms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP633841.RAPObBzUqI0R0L9irojKs8eFFZ17leYY9kCf1_zUzG-Zs130_provenance.
- NP633841.RAPObBzUqI0R0L9irojKs8eFFZ17leYY9kCf1_zUzG-Zs130_assertion evidence source_evidence_literature NP633841.RAPObBzUqI0R0L9irojKs8eFFZ17leYY9kCf1_zUzG-Zs130_provenance.
- NP633841.RAPObBzUqI0R0L9irojKs8eFFZ17leYY9kCf1_zUzG-Zs130_assertion SIO_000772 21726203 NP633841.RAPObBzUqI0R0L9irojKs8eFFZ17leYY9kCf1_zUzG-Zs130_provenance.
- NP633841.RAPObBzUqI0R0L9irojKs8eFFZ17leYY9kCf1_zUzG-Zs130_assertion wasDerivedFrom befree-20140225 NP633841.RAPObBzUqI0R0L9irojKs8eFFZ17leYY9kCf1_zUzG-Zs130_provenance.
- NP633841.RAPObBzUqI0R0L9irojKs8eFFZ17leYY9kCf1_zUzG-Zs130_assertion wasGeneratedBy ECO_0000203 NP633841.RAPObBzUqI0R0L9irojKs8eFFZ17leYY9kCf1_zUzG-Zs130_provenance.